ruthenium has been researched along with clioquinol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gobec, M; Gobec, S; Kljun, J; Mlinarič-Raščan, I; Sosič, I; Turel, I; Uršič, M | 1 |
| Glazer, EC; Heidary, DK; Howerton, BS | 1 |
| Gobec, S; Kljun, J; Kos, J; Mitrović, A; Sosič, I; Turel, I | 1 |
3 other study(ies) available for ruthenium and clioquinol
| Article | Year |
|---|---|
Structural characterization and biological evaluation of a clioquinol-ruthenium complex with copper-independent antileukaemic activity.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Clioquinol; Copper; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Jurkat Cells; Leukemia; MCF-7 Cells; NF-kappa B; Oxyquinoline; Proteasome Endopeptidase Complex; Ruthenium | 2014 |
Coordination of hydroxyquinolines to a ruthenium bis-dimethyl-phenanthroline scaffold radically improves potency for potential as antineoplastic agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Clioquinol; Coordination Complexes; Copper; HL-60 Cells; Humans; Hydroxyquinolines; Inhibitory Concentration 50; Proteasome Inhibitors; Quinolines; Ruthenium; Structure-Activity Relationship | 2014 |
Clioquinol-ruthenium complex impairs tumour cell invasion by inhibiting cathepsin B activity.
Topics: Antineoplastic Agents; Cathepsin B; Cell Line, Tumor; Clioquinol; Cymenes; Enzyme Inhibitors; Humans; Monoterpenes; Neoplasm Invasiveness; Neoplasms; Organometallic Compounds; Ruthenium | 2016 |